Your browser doesn't support javascript.
loading
A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies.
Gürgen, Dennis; Becker, Michael; Dahlmann, Mathias; Flechsig, Susanne; Schaeffeler, Elke; Büttner, Florian A; Schmees, Christian; Bohnert, Regina; Bedke, Jens; Schwab, Matthias; Wendler, Johann J; Schostak, Martin; Jandrig, Burkhard; Walther, Wolfgang; Hoffmann, Jens.
Afiliación
  • Gürgen D; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany.
  • Becker M; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany.
  • Dahlmann M; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany.
  • Flechsig S; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany.
  • Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Büttner FA; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Schmees C; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bohnert R; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Bedke J; Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.
  • Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Wendler JJ; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schostak M; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Jandrig B; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Walther W; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Hoffmann J; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Front Oncol ; 12: 889789, 2022.
Article en En | MEDLINE | ID: mdl-35800063
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania